Here are relevant reports on : artificial-intelligence-ophthalmology-market
-
Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030
The global biomaterials market, valued at US$45.15 billion in 2024, stood at US$48.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$68.93 billion by the end of the period. Biomaterials are specially crafted materials designed to interact safely with biological systems for medical applications.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic Acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030
The Europe biomaterials market, valued at US$14.21 billion in 2024, stood at US$15.21 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$21.59 billion by the end of the period. The growth of the Europe biomaterials market is driven by the adoption of higher performing materials by hospitals and device manufacturers to support healthcare in general.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Outsourced Manufacturing Market by Device Type (IVD (Equipment, Consumable), Diabetes, Respiratory, Cardiovascular, Personal Care, Endoscopy, Dental, Ophthalmology, Devices) Class of Device, Services, Procedure - Forecast to 2026
The global medical device outsourced manufacturing market growth is primed to transition from $29.3 billion in 2021 to $56.2 billion by 2026, showcasing a strong CAGR of 13.9%. The medical device outsourced manufacturing market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
The global multimodal imaging market, valued at US$3.9 billion in 2022, stood at US$4.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.5 billion by the end of the period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Surgical Lasers Market by product type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021
The global surgical lasers market is projected to grow at a CAGR of 5.1%. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the surgical lasers market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Cloud Business Intelligence Market: Worldwide Forecasts and Analysis (2014 – 2019)
Cloud Business Intelligence (BI) is a combination of technologies, tools and solutions that employ one or more cloud deployment models. Business intelligence on cloud is a delivery model that is being watched by many organizations as it offers several advantages in terms of cost benefits, flexibility of implementation, availability and speed of implementation. Cloud computing and business intelligence is an ideal match as business intelligence is about transforming data into information that businesses can use to make better decisions, while cloud computing provides an efficient and agile way to access business intelligence solutions. IBM, SAP, SAS, Salesforce.com, Microsoft, and Oracle are the major players in the cloud business intelligence market. These vendors offer their solutions catering to several industry verticals such as BFSI, retail, healthcare and life sciences, IT and telecommunication, government and public sector, research and education, manufacturing, travel and hospitality, media and communication, and others. The report provides global market trends, overall adoption scenario, competitive landscape, key drivers, restraints, concerns and opportunities in this market. The report aims at estimating the current market size and the future growth potential of this market across various verticals and regions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Veterinary Ophthalmology Equipment Market by Product (Diagnostic [Ophthalmoscopes, Tonometers], Surgical Equipment, Disposables, and Implants, Animal Type, End User (Veterinary Hospitals, Clinics) - Forecast to 2031
The US veterinary ophthalmology equipment market, valued at USD 0.24 billion in 2025, stood at USD 0.26 billion in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2031, culminating in a forecasted valuation of USD 0.38 billion by the end of the period. The market is growing at a rapid pace, driven by the increasing pet ownership, awareness of pet disease, rising expenses of pet healthcare, a growing number of veterinary ophthalmologists, rising incidences of ocular disorders in veterinary cases, and the increasing use of advanced technologies in ophthalmology.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Generative AI Outlook 2025 – Shaping the Future of Creative Intelligence
Global IT spending on devices, data center systems, enterprise software, IT services, and communications services is forecast to reach USD 5.7 trillion by 2025 (9.3% growth over 2024). OpenAI, Microsoft, Google, AWS, and Adobe are the major players in generative AI, with more than 45% combined market share in 2024. Other prominent market players are NVIDIA, Meta, Anthropic, Accenture, and IBM. In 2024, key generative AI providers strive to maintain their leadership positions with new product launches & product enhancements, multimodal AI advancements, strategic deals, and partnerships & collaborations. In 2025, Generative AI providers will invest in ethical AI frameworks, real-time multimodal capabilities, and AI democratization to enhance usability, address bias, and ensure data security, meeting the growing demand for personalized, transparent, and scalable AI solutions across industries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Ophthalmology Drugs Market by Molecule (Faricimab, Aflibercept, Ranibizumab), Modality (Monoclonal Antibodies & Fusion Proteins), RoA (Intravitreal, Topical), Indication (AMD, Diabetic Retinopathy (DR), DME), End User - Global Forecast to 2030
The global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030
The global clinical trial supplies market, valued at US$4.85 billion in 2024, stood at US$5.34 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growing complexity of clinical trials, particularly with decentralized and adaptive trial designs, has heightened the demand for efficient supply chain management solutions.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
